CLINICAL ACTIONS: The NICHD conducted a workshop in January to review evidence, with special consideration to avoid unnecessary. The American College of Obstetricians and Gynecologists (ACOG) published a Intraamniotic infection, also known as chorioamnionitis, is an. Historically, infection of the chorion, amnion, or both was termed ” chorioamnionitis.” Although this term remains in common use, the term.
|Published (Last):||25 November 2008|
|PDF File Size:||1.38 Mb|
|ePub File Size:||15.11 Mb|
|Price:||Free* [*Free Regsitration Required]|
Silverman, MD; and Yasser Y. This information is designed as an educational resource to aid clinicians in providing obstetric and gynecologic care, and use of this information is voluntary.
This information should not be considered as inclusive of all proper treatments or methods of care or as a acof of the standard of care. It is not intended to substitute choroamnionitis the independent professional judgment of the treating clinician.
Variations in practice may be warranted when, in the cuorioamnionitis judgment of the treating clinician, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology. The American College of Obstetricians and Gynecologists reviews its publications regularly; however, its publications may not reflect the most recent evidence.
Any updates to this document can be found on www. ACOG does not guarantee, warrant, or endorse the products or services of any firm, organization, or person.
Women’s Health Care Physicians
Neither ACOG nor its officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect to any liabilities, including direct, special, indirect, or consequential damages, incurred in connection with this publication or reliance on the information presented.
Intraamniotic infection, also avog as chorioamnionitis, is an infection with resultant inflammation of any combination of the amniotic fluid, placenta, fetus, fetal membranes, or decidua.
Intraamniotic infection is a common condition noted among preterm and term parturients. However, most cases of intraamniotic infection detected and managed by obstetrician—gynecologists or other obstetric care providers will be noted among term patients in labor. Intraamniotic infection can be associated with acute neonatal morbidity, including neonatal pneumonia, meningitis, sepsis, and death.
Maternal morbidity from intraamniotic infection also can be significant, and may include dysfunctional labor requiring increased intervention, postpartum uterine atony with hemorrhage, endometritis, peritonitis, sepsis, adult respiratory distress syndrome and, rarely, death. Recognition of intrapartum intraamniotic infection and implementation of treatment recommendations are essential steps that effectively can minimize morbidity and mortality for women and newborns.
Timely maternal management together with notification of the neonatal health care providers will facilitate appropriate evaluation and empiric antibiotic treatment when indicated. Intraamniotic infection alone is rarely, if ever, an indication for cesarean delivery. This remains an evolving area, and for the purposes of this document, which focuses on the management of suspected or confirmed infection, the use of the term intraamniotic infection is retained to identify this condition.
Intraamniotic infection often is polymicrobial in origin, commonly involves aerobic and anaerobic bacteria, and frequently originates from the vaginal flora 2. It predominantly occurs by ascending bacterial invasion from the lower genital tract to the typically sterile amniotic cavity. Intraamniotic infection also can occur, although rarely, after invasive procedures eg, amniocentesis or chorionic villus sampling or by a hematogenous route secondary to maternal systemic infection eg, Listeria monocytogenes.
More recent data suggest that the relative risk for intraamniotic infection and neonatal infection may increase after 40 completed weeks of gestation 3— 5. Intraamniotic infection can be associated with acute neonatal morbidity, including neonatal pneumonia, meningitis, sepsis, and death 3.
The use of intrapartum antibiotic treatment given either in response to maternal group B streptococcal colonization or in response to evolving signs of intraamniotic infection during labor has been associated with a nearly fold decrease in group B streptococcal-specific neonatal sepsis 6—8. Decreases in non-group B streptococcal neonatal infections also have been noted 9— The protective effect of maternal intrapartum antibiotic administration has been demonstrated in recent multivariate risk models of individual infant risk of neonatal sepsis 5, Intraamniotic infection can be associated with long-term complications for the infant, such as bronchopulmonary dysplasia and cerebral palsy 1314potentially due to the effect of inflammation alone.
A recent meta-analysis of 15 studies found a significantly higher relative risk of cerebral palsy among primarily premature infants exposed to either histologic chorioamnionitis odds ratio [OR], 1. It is nonetheless important to acknowledge that the overall absolute risk of cerebral palsy remains quite low approximately 2 per 1, live births Maternal morbidity from intraamniotic infection also can be significant, and may include dysfunctional labor requiring increased intervention, postpartum uterine atony with hemorrhage, endometritis, peritonitis, sepsis, adult respiratory distress syndrome and, rarely, death 16 Obstetric risk factors for intraamniotic infection at term have been delineated, including low parity, multiple digital examinations, use of internal uterine and fetal monitors, meconium-stained amniotic fluid, and the presence of certain genital tract pathogens eg, group B streptococcal infection and sexually transmitted infections 3, 18— It should be recognized that many of these proposed risk factors also are associated with longer duration of labor and membrane rupture, and may not be independently associated with intraamniotic infection.
For example, a recent retrospective investigation of more than 2, parturients specifically analyzed the number of cervical examinations performed during labor and found that women who developed an intrapartum fever had more digital cervical examinations than women who did not However, this relationship was not significant after adjusting for spontaneous labor, the Bishop score, and rupture of membranes on admission.
Maternal intraamniotic infection is reasonably sensitive but lacks specificity with regard to the diagnosis of neonatal sepsis, particularly among preterm infants.
Multivariate risk models for predicting neonatal sepsis among term and late-preterm infants have been developed based on objective data, including gestational age, duration of rupture of membranes, highest maternal intrapartum temperature, group B streptococcal colonization, and the type and timing of intrapartum antibiotic administration 5, 12, These neonatal sepsis risk models do not affect maternal intrapartum management, but the use of maternal intrapartum data underscores the importance of communication with pediatric care providers as well as of appropriate maternal medical record documentation.
The diagnosis of intraamniotic infection can be established objectively by amniotic fluid culture, or gram stain, or both and biochemical analysis, but for most women at term who are in labor the diagnosis is primarily made using clinical criteria. In a recent executive summary of proceedings from a joint workshop sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the Society for Maternal—Fetal Medicine, the American Academy of Pediatrics, and the American College of Obstetricians and Gynecologists, a panel of maternal and neonatal experts recommended separating intraamniotic infection into three different categories: Suspected intraamniotic infection is based on clinical criteria, which include maternal intrapartum fever and one or more of the following: Confirmed intraamniotic infection is based on a positive amniotic fluid test result gram stain, glucose level, or culture results consistent with infection or placental pathology demonstrating histologic evidence of placental infection or inflammation.
Intrapartum Management of Intraamniotic Infection – ACOG
In clinical practice, confirmed intraamniotic infection among women in labor at term will most commonly be made after delivery, based on histopathologic study of the placenta. Therefore, until better and less invasive intrapartum diagnostic tools become available, any practical distinction between suspected and confirmed intraamniotic infection will remain meaningful only in research settings and not for the obstetrician—gynecologist or other obstetric care provider managing a patient in labor.
Diagnosis of confirmed histologic intraamniotic infection in the postpartum period does chorioamniojitis alter postdelivery maternal treatment. As demonstrated in a randomized clinical trial, intrapartum antibiotic therapy for intraamniotic infection decreases the rate of neonatal bacteremia, pneumonia, and sepsis Multivariate models of neonatal sepsis risk demonstrate the positive effect of intrapartum antibiotics on the risk of culture-confirmed neonatal infection 5, Intrapartum antibiotics also have been shown to decrease maternal febrile morbidity and length of hospital stay.
Therefore, in the absence of any clearly documented overriding risks, administration of intrapartum antibiotics is recommended whenever intraamniotic infection is suspected or confirmed Antipyretics should be administered in addition to antibiotics. Proper labor progression should be chorioamnioitis, given the association between intraamniotic infection and dysfunctional labor progression 3, 16, 17, In the absence of contraindications, augmentation of protracted labor in women with intraamniotic infection appears prudent.
However, intraamniotic infection alone is not an indication for immediate delivery, and the route of delivery in most situations chorikamnionitis be based on standard obstetric indications.
In clinical care, an isolated maternal fever is a common scenario facing obstetrician—gynecologists or other obstetric care providers and, even absent additional criteria or persistent temperature fhorioamnionitis as defined in the expert workshop executive summaryin practice clinicians often choose to treat for intraamniotic infection.
Few data exist to guide appropriate management of women with isolated intrapartum fever in the absence of other clinical signs suggesting intraamniotic infection.
Diagnosis and Management of Clinical Chorioamnionitis
Isolated intrapartum fever alone, whether due to infection or not, also has been associated with poor short-term and long-term neonatal outcomes 28— The exact mechanism of such an effect remains unclear, although fetal hyperthermia and associated changes in metabolic rate is hypothesized to potentiate the negative effects of tissue hypoxia.
Prospective, randomized controlled studies are needed to better guide management of isolated intrapartum fever. Currently, given the potential benefits for the woman and newborn, antibiotics should be considered in the setting of isolated maternal fever unless a source other than intraamniotic infection is identified and documented.
In some settings, this approach may result in increased awareness and diagnosis of intraamniotic infection, which will affect subsequent management of newborns. Whether or not a decision is made to initiate intrapartum antimicrobial therapy, the occurrence of maternal intrapartum fever avog be communicated to choripamnionitis neonatal care team.
Newer pediatric recommendations rely less on the clinical diagnosis of suspected intraamniotic infection, and more on consideration of a variety of risk factors and newborn clinical status to determine neonatal management. Intrapartum antimicrobial agents administered for suspected or confirmed intraamniotic infection should not be continued automatically postpartum; rather, extension of antimicrobial therapy should be based on risk factors for postpartum endometritis 31— Data suggest that women who have vaginal deliveries are less likely to have endometritis and may not require postpartum antibiotics For women undergoing cesarean deliveries, at least one additional dose of antimicrobial agents after delivery is recommended.
However, the presence of other maternal risk factors such as vhorioamnionitis or persistent fever in the postpartum period may be used to guide continuation of antimicrobial therapy, duration of antimicrobial therapy, or both in vaginal and cesarean deliveries.
Common antibiotic choices for treatment of suspected intraamniotic infection are listed in Table choriomnionitis. Obstetrician—gynecologists and other obstetric care providers also should consider consulting their local microbiology laboratory and infectious disease experts to ascertain whether there are alternative recommended regimens based on local antibiotic resistance patterns.
The Centers for Disease Control and Prevention and the American Academy of Pediatrics provide guidelines for assessing risk of neonatal infection 7, 35— These guidelines recommend laboratory studies and empiric antibiotic therapy for all newborns delivered from women with a suspected or confirmed intraamniotic infection.
Currently chorioamnionihis recommendations are being chorioamnionotis 1, Recent data on the development of the neonatal microbiome and the role of early antibiotic exposures suggest that antibiotic therapy may not be entirely benign 39— Multivariate risk assessment and increased reliance on clinical observation may safely decrease the number chorioambionitis well-appearing term newborns treated empirically with chorioamnionutis 5, 12, In all cases, isolated maternal fever and chorioamnioniris or confirmed intraamniotic infection should be communicated to neonatal caregivers at birth.
Regardless of evolving national recommendations and local variations in approach, such infants always will require enhanced clinical surveillance for signs of developing infection. Recognition of intrapartum intraamniotic infection and implementation of choriaomnionitis treatment recommendations are essential steps that can effectively minimize morbidity chorioamnionitiw mortality for women and newborns.
No part of this publication may be reproduced, stored in a retrieval system, posted on the Internet, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without prior written permission from the publisher. Intrapartum management of intraamniotic infection. American College of Obstetricians and Gynecologists. Women’s Health Care Physicians.
Recommendations The American College of Obstetricians chorkoamnionitis Gynecologists makes the following recommendations: Intraamniotic infection, also referred to as chorioamnionitis, is an infection with resultant inflammation of any combination of the amniotic fluid, placenta, fetus, fetal membranes, or decidua. Intraamniotic infection can be associated with acute neonatal morbidity, including neonatal pneumonia, meningitis, sepsis, and death, as well as long-term infant complications such as bronchopulmonary dysplasia and cerebral palsy.
For the purposes of this Committee Opinion, the diagnosis of suspected intraamniotic infection is made cjorioamnionitis the maternal temperature is greater than or equal to For the purposes of this Committee Chorioamnoinitis, isolated maternal fever is defined as any maternal temperature between Administration of intrapartum antibiotics is recommended whenever an intraamniotic infection is suspected or confirmed.
Antibiotics should be considered in the setting of isolated maternal fever unless a source other than intraamniotic infection is identified and documented. Regardless of institutional protocol, when obstetrician—gynecologists or other obstetric care providers diagnose an intraamniotic infection, or when other risk factors for early-onset neonatal sepsis are present in labor eg, maternal fever, prolonged rupture of the membranes, or preterm birthcommunication choiroamnionitis the neonatal care team is essential to optimize neonatal evaluation and management.
Background Intraamniotic infection, also known as chorioamnionitis, is an infection with resultant inflammation of any combination of the amniotic fluid, placenta, fetus, fetal membranes, or decidua. Presumptive Diagnosis of Intraamniotic Infection The diagnosis of intraamniotic infection can be established objectively by amniotic fluid culture, or gram stain, or both and biochemical analysis, but for most women at term who are in labor the diagnosis is primarily made using clinical criteria.
Management of Suspected or Confirmed Intraamniotic Infection As demonstrated in a randomized clinical trial, intrapartum antibiotic therapy for intraamniotic infection decreases the rate of neonatal bacteremia, pneumonia, and sepsis Postdelivery Recommendations Intrapartum antimicrobial agents administered for suspected or confirmed intraamniotic infection should not be continued automatically postpartum; rather, extension of antimicrobial therapy should be based on risk factors for postpartum endometritis 31— Conclusion Intraamniotic infection is a common condition noted among preterm and term parturients.
Evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis: Intraamniotic infection in low-birth-weight infants. J Infect Dis ; Chorioamnionitis and intraamniotic infection. Clin Obstet Gynecol ; Acute chorioamnionitis and funisitis: Am J Obstet Gynecol ;